News
Abaloparatide works in ‘ignored population’: Men with osteoporosis
- Author:
- Miriam E. Tucker
Study finds increased bone mineral density from baseline to 1 year in men with osteoporosis.
News
First fatty liver guidelines for endocrinology, primary care
- Author:
- Miriam E. Tucker
Endocrinologists and primary care docs “need to be the ones who are diagnosing and managing [non-alcoholic fatty liver disease] because there just...
News
Screening for diabetes at normal BMIs could cut racial disparities
- Author:
- Miriam E. Tucker
Diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be ‘a good place to...
News
Undertreated hypothyroidism may worsen hospital outcomes
- Author:
- Miriam E. Tucker
Large database study finds association between suboptimal hypothyroidism treatment and longer hospital stay, higher readmission rate.
News
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
- Author:
- Miriam E. Tucker
The once-weekly investigational twincretin drug is in phase 3 development for obesity and under regulatory review, with a decision expected soon...
News
‘Profound implications’: COVID ups diabetes risk 40% a year later
- Author:
- Miriam E. Tucker
‘All these roads are pointing in one direction, that COVID-19 increases the risk of diabetes up to a year later. If patients have a prior history...
News
Mild COVID-19 infection linked to later type 2 diabetes
- Author:
- Miriam E. Tucker
Results point to the need to monitor blood glucose following SARS-CoV-2 infection.
News
COVID-19 doesn’t spike A1c levels
- Author:
- Miriam E. Tucker
Investigators found a statistically significant but clinically insignificant A1c increase following a positive...
News
Ukrainian diabetes care, insulin access ‘severely disrupted’
- Author:
- Miriam E. Tucker
“I’m willing to see patients but it’s extremely difficult and dangerous for them and probably not possible to travel to see me.”
News
Can a tool help overcome barriers to diabetes medication cost?
- Author:
- Miriam E. Tucker
Tool is designed to be a ‘broad conversation starter’ and not just about medications.
News
Is a blood test for type 1 diabetes in kids worth the cost?
- Author:
- Miriam E. Tucker
A new study from Germany estimates the potential costs involved in blood tests for type 1 diabetes in early childhood, but that’s only one part of...
News
Next-generation Dexcom CGM, G7, accurate and easier to use
- Author:
- Miriam E. Tucker
The Dexcom G7 continuous glucose monitor for patients with diabetes will include several features considered to be improvements over the G6...
News
Estrogen supplementation may reduce COVID-19 death risk
- Author:
- Miriam E. Tucker
“This study shows an association between estrogen levels and COVID-19 death.”
News
FDA okays 6-month implanted Eversense CGM for diabetes
- Author:
- Miriam E. Tucker
The Senseonics Eversense E3 System is expected to be available in the U.S. in the second quarter of 2022 for use in adults with diabetes.
News
Do latest SURPASS findings with twincretin in diabetes impress?
- Author:
- Miriam E. Tucker
Adding the investigational twincretin tirzepatide (Eli Lilly) to insulin glargine significantly improves blood...